Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07715305 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 20, 2026 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
The study compare and evaluate the bioequivalence between the administration of AD-116A and the administration of AD-1161 in healthy adult male volunteers
Trial Details
NCT Number NCT07715305
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Benign Prostatic Hyperplasia
Related terms Prostatic Hyperplasia
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov